Agoracom: Small Cap Investment - Resverlogix Corp. - Re: New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension

BearDownAZ

Sep 03, 2018 11:34PM

Cabel

Rank: Treasurer [?]

Points: 1655 [?]

Votes: 16 Score: 2.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension

in response to

New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension

BearDownAZ

posted on Sep 04, 2018 12:28AM

Nice!

PAH global market estimated to reach just over $5 billion US by year 2020.

https://globenewswire.com/news-release/2018/07/24/1541108/0/en/Pulmonary-Arterial-Hypertension-Market-to-reach-a-valuation-of-US-5-19-Bn-by-2020-Says-TMR.html

4 Recommendations

Re: New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension

KOO-KOO2

Sep 04, 2018 05:51AM

Re: New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension

PomponiusCapital

Feb 23, 2019 03:16PM

Re: New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension

BearDownAZ

May 02, 2019 10:48PM

Re: New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension

BearDownAZ